Advice
In the absence of a submission from the holder of the marketing authorisation.
duloxetine (Cymbalta®) is not recommended for use within NHSScotland for the treatment of generalised anxiety disorder.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice24KB (PDF)
Medicine details
- Medicine name:
- duloxetine (Cymbalta)
- SMC ID:
- 514/08
- Indication:
- Generalised anxiety disorder
- Pharmaceutical company
- Eli Lilly and Company Ltd
- BNF chapter
- Central nervous system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 October 2008